(TEAR, BLRX, PLCM) CRWENewswire Stocks In Action

Social
Share

0 (0 Likes / 0 Dislikes)

Embed Video
Embed normal player Copy to Clipboard
Embed a smaller player Copy to Clipboard
Advanced Embedding Options
Embedding Options

Size:

Language:

Embed Code

Copy to Clipboard
Invite a user to Dotsub

Your invitation to join Dotsub was successful

There was an error inviting that user to Dotsub

Video Details

Duration: 1 minute and 15 seconds

Country: United States

Language: English

License: CC - Attribution No Derivatives

Genre: News Broadcast

Posted by: karmastock on Jan 24, 2012

BioLineRx Ltd -BLRX - reported that it has signed a worldwide, exclusive license agreement with Genoscience, to develop and commercialize BL-8020, an orally available treatment for Hepatitis C.

Report this video as offensive

(TEAR, BLRX, PLCM) CRWENewswire Stocks In Action

Embed Video

Video Details

Caption and Translate

Other videos from karmastock

CRWENewswire CEO Interviews: Alan Stone & Company, LLC

(DAVE, CRWE, ROYL) CRWENewswire Stocks to Watch